TY - JOUR
T1 - Analysis of biological interactions by affinity chromatography
T2 - Clinical and pharmaceutical applications
AU - Hage, David S.
N1 - Funding Information:
D.S. Hage, Portions of this work were institutionally supported by the NIH under grants R01 GM044931 and R01 DK069629.
Publisher Copyright:
© 2016 American Association for Clinical Chemistry.
PY - 2017/6
Y1 - 2017/6
N2 - Background: The interactions between biochemical and chemical agents in the body are important in many clinical processes. Affinity chromatography and highperformance affinity chromatography (HPAC), in which a column contains an immobilized biologically related binding agent, are 2 methods that can be used to study these interactions. Content: This review presents various approaches that can be used in affinity chromatography and HPAC to characterize the strength or rate of a biological interaction, the number and types of sites that are involved in this process, and the interactions between multiple solutes for the same binding agent. A number of applications for these methods are examined, with an emphasis on recent developments and high-performance affinity methods. These applications include the use of these techniques for fundamental studies of biological interactions, high-throughput screening of drugs, work with modified proteins, tools for personalized medicine, and studies of drug-drug competition for a common binding agent. Summary: The wide range of formats and detection methods that can be used with affinity chromatography and HPAC for examining biological interactions makes these tools attractive for various clinical and pharmaceutical applications. Future directions in the development of small-scale columns and the coupling of these methods with other techniques, such as mass spectrometry or other separation methods, should continue to increase the flexibility and ease with which these approaches can be used in work involving clinical or pharmaceutical samples.
AB - Background: The interactions between biochemical and chemical agents in the body are important in many clinical processes. Affinity chromatography and highperformance affinity chromatography (HPAC), in which a column contains an immobilized biologically related binding agent, are 2 methods that can be used to study these interactions. Content: This review presents various approaches that can be used in affinity chromatography and HPAC to characterize the strength or rate of a biological interaction, the number and types of sites that are involved in this process, and the interactions between multiple solutes for the same binding agent. A number of applications for these methods are examined, with an emphasis on recent developments and high-performance affinity methods. These applications include the use of these techniques for fundamental studies of biological interactions, high-throughput screening of drugs, work with modified proteins, tools for personalized medicine, and studies of drug-drug competition for a common binding agent. Summary: The wide range of formats and detection methods that can be used with affinity chromatography and HPAC for examining biological interactions makes these tools attractive for various clinical and pharmaceutical applications. Future directions in the development of small-scale columns and the coupling of these methods with other techniques, such as mass spectrometry or other separation methods, should continue to increase the flexibility and ease with which these approaches can be used in work involving clinical or pharmaceutical samples.
UR - http://www.scopus.com/inward/record.url?scp=85019666337&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85019666337&partnerID=8YFLogxK
U2 - 10.1373/clinchem.2016.262253
DO - 10.1373/clinchem.2016.262253
M3 - Review article
C2 - 28396561
AN - SCOPUS:85019666337
SN - 0009-9147
VL - 63
SP - 1083
EP - 1093
JO - Clinical Chemistry
JF - Clinical Chemistry
IS - 6
ER -